Clumps of ovarian clear cell carcinoma cells formed when the two genes ARID1A and PIK3CA were mutated in mice. Credit: Ron Chandler, Ph.D., UNC School of Medicine
In the battle against ovarian cancer, UNC School of Medicine researchers have created the first mouse model of the worst form of the disease and found a potential route to better treatments and much-needed diagnostic screens.
Led by Terry Magnuson, PhD, the Sarah Graham Kenan Professor and chair of the department of genetics, a team of UNC genetics researchers discovered how two genes interact to trigger cancer and then spur on its development.
"It's an extremely aggressive model of the disease, which is how this form of ovarian cancer presents in women," said Magnuson, who is also a member of the UNC Lineberger Comprehensive Cancer Center. Not all mouse models of human diseases provide accurate depictions of the human condition. Magnuson's mouse model, though, is based on genetic mutations found in human cancer samples.
Mutations in two genes -ARID1A and PIK3CA - were previously unknown to cause cancer. "When ARID1A is less active than normal and PIK3CA is overactive," Magnuson said, "the result is ovarian clear cell carcinoma 100 percent of the time in our model."
The research also showed that a drug called BKM120, which suppresses PI3 kinases, directly inhibited tumor growth and significantly prolonged the lives of mice. The drug is currently being tested in human clinical trials for other forms of cancer.
The work, published today in the journal Nature Communications, was spearheaded by Ron Chandler, PhD, a postdoctoral fellow in Magnuson's lab. Chandler had been studying the ARID1A gene - which normally functions as a tumor suppressor in people - when results from cancer genome sequencing projects showed that the ARID1A gene was highly mutated in several types of tumors, including ovarian clear cell carcinoma. Chandler began researching the gene's precise function in that disease and found that deleting it in mice did not cause tumor formation or tumor growth.
Left image shows: normal mouse ovary. Right image shows: mouse ovary with tumors after for weeks due to specific mutations in the genes ARID1A and PIK3CA. Credit: Ron Chandler, Ph.D., UNC School of Medicine
"We found that the mice needed an additional mutation in the PIK3CA gene, which acts like a catalyst of a cellular pathway important for cell growth," Chandler said. Proper cell cycle regulation is crucial for normal cell growth. When it goes awry, cells can turn cancerous.
"Our research shows why we see mutations of both ARID1A and PIK3CA in various cancers, such as endometrial and gastric cancers," Chandler said. "Too little expression of ARID1A and too much expression of PIK3CA is the perfect storm; the mice always get ovarian clear cell carcinoma. This pair of genes is really important for tumorigenesis."
Magnuson's team also found that ARID1A and PIC3CA mutations led to the overproduction of Interleukin-6, or IL-6, which is a cytokine - a kind of protein crucial for cell signaling that triggers inflammation. "We don't know if inflammation causes ovarian clear cell carcinoma, but we do know it's important for tumor cell growth," Chandler said.
Magnuson added, "We think that IL-6 contributes to ovarian clear cell carcinoma and could lead to death. You really don't want this cytokine circulating in your body."
Magnuson added that treating tumor cells with an IL-6 antibody suppressed cell growth, which is why reducing IL-6 levels could help patients.
Although this research is necessary to find better cancer treatments, Magnuson and Chandler say that their finding could open the door to better screening tools.
"If we can find something measurable that's downstream of ARID1A - such as a cell surface protein or something else we could tease apart - then we could use it as a biomarker of disease," Chandler said. "We could create a way to screen women. Right now, by the time women find out they have ovarian clear cell carcinoma, it's usually too late. If we can find it earlier, we'll have much better luck successfully treating patients."
Explore further: Protein induces self-destruction in cancer cells
Medical Xpress on facebook
Related Stories
Researchers identify genes tied to deadliest ovarian cancers
Sep 08, 2010
Scientists at the Johns Hopkins Kimmel Cancer Center have identified two genes whose mutations appear to be linked to ovarian clear cell carcinoma, one of the most aggressive forms of ovarian cancer. Clear cell carcinoma ...
Protein induces self-destruction in cancer cells
Jan 21, 2015
The role of a phosphatase protein in promoting the self-destruction of healthy cells and the progression of ovarian cancer has been identified by A*STAR researchers. Known to be overexpressed in cancer cells, ...
Finding the Achilles' Heel of ovarian tumor growth
Jun 19, 2014
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that ...
Scaffolding protein promotes growth and metastases of epithelial ovarian cancer
Apr 07, 2014
Researchers from Fox Chase Cancer Center have shown that NEDD9, a scaffolding protein responsible for regulating signaling pathways in the cell, promotes the growth and spread of epithelial ovarian cancer.
Cancer-killing virus combined with a chemotherapy drug might effectively treat recurrent ovarian cancer
Nov 13, 2014
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and ...
Recommended for you
Live long and prosper? Decoupling lifespan and healthspan in aging research
19 hours ago
(Medical Xpress)—A long-standing assumption in aging research, and therefore in resulting antiaging interventions, is that modifying genetic and environmental factors to extend lifespan also increases healthspan – th ...
Researchers solve metabolic mystery lending insight into Lafora disease
21 hours ago
Scientists at the University of Kentucky College of Medicine have determined how an enzyme essential for energy metabolism functions, solving a mystery eluding molecular biologists for decades.
Telomere extension turns back aging clock in cultured human cells, study finds
Jan 23, 2015
A new procedure can quickly and efficiently increase the length of human telomeres, the protective caps on the ends of chromosomes that are linked to aging and disease, according to scientists at the Stanford ...
Gene may open door for improved keloid, scar treatment
Jan 23, 2015
Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, ...
New 'systems genetics' study identifies possible target for epilepsy treatment
Jan 23, 2015
A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new treatments, according to research.
Team sees effect of BPA and estradiol on sperm development
Jan 22, 2015
Washington State University researchers have found a direct link between the plastics component bisphenol A, or BPA, and disrupted sperm production. Writing in the journal PLOS Genetics, they say the chemic ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Clumps of ovarian clear cell carcinoma cells formed when the two genes ARID1A and PIK3CA were mutated in mice. Credit: Ron Chandler, Ph.D., UNC School of Medicine
In the battle against ovarian cancer, UNC School of Medicine researchers have created the first mouse model of the worst form of the disease and found a potential route to better treatments and much-needed diagnostic screens.
Led by Terry Magnuson, PhD, the Sarah Graham Kenan Professor and chair of the department of genetics, a team of UNC genetics researchers discovered how two genes interact to trigger cancer and then spur on its development.
"It's an extremely aggressive model of the disease, which is how this form of ovarian cancer presents in women," said Magnuson, who is also a member of the UNC Lineberger Comprehensive Cancer Center. Not all mouse models of human diseases provide accurate depictions of the human condition. Magnuson's mouse model, though, is based on genetic mutations found in human cancer samples.
Mutations in two genes -ARID1A and PIK3CA - were previously unknown to cause cancer. "When ARID1A is less active than normal and PIK3CA is overactive," Magnuson said, "the result is ovarian clear cell carcinoma 100 percent of the time in our model."
The research also showed that a drug called BKM120, which suppresses PI3 kinases, directly inhibited tumor growth and significantly prolonged the lives of mice. The drug is currently being tested in human clinical trials for other forms of cancer.
The work, published today in the journal Nature Communications, was spearheaded by Ron Chandler, PhD, a postdoctoral fellow in Magnuson's lab. Chandler had been studying the ARID1A gene - which normally functions as a tumor suppressor in people - when results from cancer genome sequencing projects showed that the ARID1A gene was highly mutated in several types of tumors, including ovarian clear cell carcinoma. Chandler began researching the gene's precise function in that disease and found that deleting it in mice did not cause tumor formation or tumor growth.
Left image shows: normal mouse ovary. Right image shows: mouse ovary with tumors after for weeks due to specific mutations in the genes ARID1A and PIK3CA. Credit: Ron Chandler, Ph.D., UNC School of Medicine
"We found that the mice needed an additional mutation in the PIK3CA gene, which acts like a catalyst of a cellular pathway important for cell growth," Chandler said. Proper cell cycle regulation is crucial for normal cell growth. When it goes awry, cells can turn cancerous.
"Our research shows why we see mutations of both ARID1A and PIK3CA in various cancers, such as endometrial and gastric cancers," Chandler said. "Too little expression of ARID1A and too much expression of PIK3CA is the perfect storm; the mice always get ovarian clear cell carcinoma. This pair of genes is really important for tumorigenesis."
Magnuson's team also found that ARID1A and PIC3CA mutations led to the overproduction of Interleukin-6, or IL-6, which is a cytokine - a kind of protein crucial for cell signaling that triggers inflammation. "We don't know if inflammation causes ovarian clear cell carcinoma, but we do know it's important for tumor cell growth," Chandler said.
Magnuson added, "We think that IL-6 contributes to ovarian clear cell carcinoma and could lead to death. You really don't want this cytokine circulating in your body."
Magnuson added that treating tumor cells with an IL-6 antibody suppressed cell growth, which is why reducing IL-6 levels could help patients.
Although this research is necessary to find better cancer treatments, Magnuson and Chandler say that their finding could open the door to better screening tools.
"If we can find something measurable that's downstream of ARID1A - such as a cell surface protein or something else we could tease apart - then we could use it as a biomarker of disease," Chandler said. "We could create a way to screen women. Right now, by the time women find out they have ovarian clear cell carcinoma, it's usually too late. If we can find it earlier, we'll have much better luck successfully treating patients."
Explore further: Protein induces self-destruction in cancer cells
Medical Xpress on facebook
Related Stories
Researchers identify genes tied to deadliest ovarian cancers
Sep 08, 2010
Scientists at the Johns Hopkins Kimmel Cancer Center have identified two genes whose mutations appear to be linked to ovarian clear cell carcinoma, one of the most aggressive forms of ovarian cancer. Clear cell carcinoma ...
Protein induces self-destruction in cancer cells
Jan 21, 2015
The role of a phosphatase protein in promoting the self-destruction of healthy cells and the progression of ovarian cancer has been identified by A*STAR researchers. Known to be overexpressed in cancer cells, ...
Finding the Achilles' Heel of ovarian tumor growth
Jun 19, 2014
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that ...
Scaffolding protein promotes growth and metastases of epithelial ovarian cancer
Apr 07, 2014
Researchers from Fox Chase Cancer Center have shown that NEDD9, a scaffolding protein responsible for regulating signaling pathways in the cell, promotes the growth and spread of epithelial ovarian cancer.
Cancer-killing virus combined with a chemotherapy drug might effectively treat recurrent ovarian cancer
Nov 13, 2014
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and ...
Recommended for you
Live long and prosper? Decoupling lifespan and healthspan in aging research
19 hours ago
(Medical Xpress)—A long-standing assumption in aging research, and therefore in resulting antiaging interventions, is that modifying genetic and environmental factors to extend lifespan also increases healthspan – th ...
Researchers solve metabolic mystery lending insight into Lafora disease
21 hours ago
Scientists at the University of Kentucky College of Medicine have determined how an enzyme essential for energy metabolism functions, solving a mystery eluding molecular biologists for decades.
Telomere extension turns back aging clock in cultured human cells, study finds
Jan 23, 2015
A new procedure can quickly and efficiently increase the length of human telomeres, the protective caps on the ends of chromosomes that are linked to aging and disease, according to scientists at the Stanford ...
Gene may open door for improved keloid, scar treatment
Jan 23, 2015
Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, ...
New 'systems genetics' study identifies possible target for epilepsy treatment
Jan 23, 2015
A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new treatments, according to research.
Team sees effect of BPA and estradiol on sperm development
Jan 22, 2015
Washington State University researchers have found a direct link between the plastics component bisphenol A, or BPA, and disrupted sperm production. Writing in the journal PLOS Genetics, they say the chemic ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment